Literature DB >> 24631480

Differential miRNA expression defines migration and reduced apoptosis in follicular thyroid carcinomas.

Bartosz Wojtas1, Carolina Ferraz2, Tomasz Stokowy3, Steffen Hauptmann4, Dariusz Lange5, Henning Dralle6, Thomas Musholt7, Barbara Jarzab8, Ralf Paschke9, Markus Eszlinger10.   

Abstract

The objective of the study was to identify microRNAs (miRs) characteristic for follicular thyroid carcinoma (FTC) and to define their role in tumorigenesis. A miR-microarray study was conducted to identify miRs differentially expressed between FTCs and their surrounding tissues. Selection was further reinforced by a literature review. Four miRs were selected and confirmed by RT-qPCR: miR-146b, -183, -221 were up-regulated, whereas miR-199b down-regulated in FTCs. The influence of these miRs on cell proliferation, cell cycle, apoptosis and migration was studied in HTori and FTC-133 cells. Functional characterization suggests an impact of miR-183 and miR-146b in FTC development. Overexpression of both miRs significantly induces migration. Moreover, overexpression of miR-183 significantly represses apoptosis. MiR-199b and -221 do not have significant effects on proliferation, cell cycle, apoptosis or migration in HTori and FTC-133 cells. Our data suggest that miR-146b and miR-183 may influence FTC development through the induction of migration and apoptosis inhibition.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Apoptosis; Follicular thyroid cancer; Migration; miRNA

Mesh:

Substances:

Year:  2014        PMID: 24631480     DOI: 10.1016/j.mce.2014.02.011

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  29 in total

1.  miR-183 and miR-21 expression as biomarkers of progression and survival in tongue carcinoma patients.

Authors:  Gordana Supic; Katarina Zeljic; Aleksandra Divac Rankov; Ruzica Kozomara; Aleksandra Nikolic; Dragica Radojkovic; Zvonko Magic
Journal:  Clin Oral Investig       Date:  2017-06-14       Impact factor: 3.573

Review 2.  MicroRNAs in the thyroid.

Authors:  Myriem Boufraqech; Joanna Klubo-Gwiezdzinska; Electron Kebebew
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2016-11-01       Impact factor: 4.690

Review 3.  Altered Epigenetic Mechanisms in Thyroid Cancer Subtypes.

Authors:  Maryam Zarkesh; Azita Zadeh-Vakili; Fereidoun Azizi; Forough Foroughi; Maziar Mohammad Akhavan; Mehdi Hedayati
Journal:  Mol Diagn Ther       Date:  2018-02       Impact factor: 4.074

4.  MicroRNA-146b promotes PI3K/AKT pathway hyperactivation and thyroid cancer progression by targeting PTEN.

Authors:  Julia Ramírez-Moya; León Wert-Lamas; Pilar Santisteban
Journal:  Oncogene       Date:  2018-01-22       Impact factor: 9.867

5.  MiR-26a inhibits thyroid cancer cell proliferation by targeting ARPP19.

Authors:  Yanping Gong; Wenshuang Wu; Xiuhe Zou; Feng Liu; Tao Wei; Jingqiang Zhu
Journal:  Am J Cancer Res       Date:  2018-06-01       Impact factor: 6.166

6.  Large sporadic thyroid medullary carcinomas: predictive factors for lymph node involvement.

Authors:  Sébastien Aubert; Amandine Berdelou; Viviane Gnemmi; Hélène Behal; Robert Caiazzo; Michèle D'herbomez; Pascal Pigny; Jean Louis Wemeau; Bruno Carnaille; Florence Renaud; Brigitte Bouchindhomme; Emmanuelle Leteurtre; Michael Perrais; François Pattou; Christine Do Cao
Journal:  Virchows Arch       Date:  2018-02-01       Impact factor: 4.064

Review 7.  MicroRNAs as potential biomarkers in cancer: opportunities and challenges.

Authors:  Huiyin Lan; Haiqi Lu; Xian Wang; Hongchuan Jin
Journal:  Biomed Res Int       Date:  2015-03-22       Impact factor: 3.411

8.  Integrated microRNA, gene expression and transcription factors signature in papillary thyroid cancer with lymph node metastasis.

Authors:  Nurul-Syakima Ab Mutalib; Sri Noraima Othman; Azliana Mohamad Yusof; Shahrun Niza Abdullah Suhaimi; Rohaizak Muhammad; Rahman Jamal
Journal:  PeerJ       Date:  2016-06-15       Impact factor: 2.984

9.  MiR-367 negatively regulates apoptosis induced by adriamycin in osteosarcoma cells by targeting KLF4.

Authors:  Guang-Chao Wang; Qian-Yun He; Da-Ke Tong; Chuan-Feng Wang; Kang Liu; Chen Ding; Fang Ji; Hao Zhang
Journal:  J Bone Oncol       Date:  2016-02-17       Impact factor: 4.072

10.  Suppressive action of miRNAs to ARP2/3 complex reduces cell migration and proliferation via RAC isoforms in Hirschsprung disease.

Authors:  Weibing Tang; Peng Cai; Weiwei Huo; Hongxing Li; Junwei Tang; Dongmei Zhu; Hua Xie; Pingfa Chen; Bo Hang; Shouyu Wang; Yankai Xia
Journal:  J Cell Mol Med       Date:  2016-03-16       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.